MedPath

Vivex Biologics, Inc

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

A Clinical Study Evaluating the Safety and Effectiveness of VIA Disc NP in Subjects With Symptomatic Disc Degeneration

Not Applicable
Recruiting
Conditions
Degenerative Disc Disease
Disc Degeneration
Lumbar Discogenic Pain
First Posted Date
2025-01-16
Last Posted Date
2025-02-27
Lead Sponsor
VIVEX Biologics, Inc.
Target Recruit Count
60
Registration Number
NCT06778447
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Premier Spine and Pain Institute, Thornton, Colorado, United States

๐Ÿ‡บ๐Ÿ‡ธ

Spine Institute of Louisiana, Shreveport, Louisiana, United States

ASCEND: A Clinical Trial to Evaluate the Safety and Effectiveness of VIA Disc NP, a Supplement for Degenerated Intervertebral Discs

Phase 2
Recruiting
Conditions
Degenerative Disc Disease
Disc Degeneration
Lumbar Discogenic Pain
Interventions
Other: VIA Disc NP
Other: Sham Injection
First Posted Date
2024-09-26
Last Posted Date
2025-02-14
Lead Sponsor
VIVEX Biologics, Inc.
Target Recruit Count
110
Registration Number
NCT06615505
Locations
๐Ÿ‡ฆ๐Ÿ‡บ

Genesis Research Services Pty Ltd, Broadmeadow, New South Wales, Australia

๐Ÿ‡ฆ๐Ÿ‡บ

Australian Medical Research, Hurstville, New South Wales, Australia

๐Ÿ‡ฆ๐Ÿ‡บ

Sydney Pain Research Centre, Wahroonga, New South Wales, Australia

and more 2 locations

VIA Disc NP Registry 3.0

Recruiting
Conditions
Discogenic Pain
Back Pain
Back Pain, Low
Interventions
Other: VIA Disc NP
First Posted Date
2024-04-03
Last Posted Date
2024-06-28
Lead Sponsor
VIVEX Biologics, Inc.
Target Recruit Count
500
Registration Number
NCT06345690
Locations
๐Ÿ‡บ๐Ÿ‡ธ

MD Pain, Englewood, Colorado, United States

๐Ÿ‡บ๐Ÿ‡ธ

The Orthopedic Research Foundation, Inc., Fishers, Indiana, United States

๐Ÿ‡บ๐Ÿ‡ธ

Procura Pain & Spine, Shenandoah, Texas, United States

and more 19 locations

VIA Disc Nucleus Pulposus Older Patients Pilot

Not Applicable
Active, not recruiting
Conditions
Degenerative Disc Disease
Disc Degeneration
Low Back Pain
Interventions
Other: VIA Disc Nucleus Pulposus Allograft
First Posted Date
2022-06-09
Last Posted Date
2024-04-29
Lead Sponsor
VIVEX Biologics, Inc.
Target Recruit Count
21
Registration Number
NCT05412277
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Paradigm Spine Care & Interventional Pain, Slidell, Louisiana, United States

๐Ÿ‡บ๐Ÿ‡ธ

Center for Clinical Research, Winston-Salem, North Carolina, United States

๐Ÿ‡บ๐Ÿ‡ธ

Florida Spine & Pain Specialists, Tampa, Florida, United States

and more 2 locations

VIA Disc NP Pilot for Patients With Symptomatic Degenerated Discs

Not Applicable
Active, not recruiting
Conditions
Degenerative Disc Disease
Disc Degeneration
Low Back Pain
Interventions
Other: VIA Disc NP
First Posted Date
2022-01-21
Last Posted Date
2024-04-29
Lead Sponsor
VIVEX Biologics, Inc.
Target Recruit Count
35
Registration Number
NCT05201287
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Virginia iSpine, Richmond, Virginia, United States

๐Ÿ‡บ๐Ÿ‡ธ

Cleveland Clinic, Cleveland, Ohio, United States

๐Ÿ‡บ๐Ÿ‡ธ

Source Health, Santa Monica, California, United States

and more 3 locations

Wound Healing Following Penile Prosthesis Implant

Not Applicable
Terminated
Conditions
Erectile Dysfunction
Interventions
Biological: VIAGENEX Max
Procedure: Hibiclens wash
First Posted Date
2022-01-19
Last Posted Date
2024-03-01
Lead Sponsor
VIVEX Biologics, Inc.
Target Recruit Count
32
Registration Number
NCT05196191
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Atlanta Cosmetic Urology, Atlanta, Georgia, United States

Study of AlloGenยฎ Liquid Intra-articular Injection for Knee Osteoarthritis

Phase 1
Withdrawn
Conditions
Osteoarthritis, Knee
Interventions
Biological: AlloGen Liquid
Drug: Placebo
First Posted Date
2021-04-08
Last Posted Date
2021-07-08
Lead Sponsor
VIVEX Biologics, Inc.
Registration Number
NCT04835389

VIA Disc NP Registry

Terminated
Conditions
Back Pain
Discogenic Pain
Back Pain, Low
Interventions
Other: VIA Disc NP (HCT/P)
First Posted Date
2020-12-03
Last Posted Date
2024-05-10
Lead Sponsor
VIVEX Biologics, Inc.
Target Recruit Count
83
Registration Number
NCT04652687
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Orthopaedic Research Foundation, Indianapolis, Indiana, United States

๐Ÿ‡บ๐Ÿ‡ธ

Advanced Spine and Pain Center, San Antonio, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Gateway Pain Solutions, Mesa, Arizona, United States

and more 29 locations

Viable Allograft Supplemented Disc Regeneration in the Treatment of Patients With Low Back Pain

Not Applicable
Conditions
Degenerative Disc Disease
Interventions
Other: Placebo
Other: Active Allograft
First Posted Date
2018-10-17
Last Posted Date
2021-07-07
Lead Sponsor
VIVEX Biologics, Inc.
Target Recruit Count
218
Registration Number
NCT03709901
Locations
๐Ÿ‡บ๐Ÿ‡ธ

OrthoIndy, Indianapolis, Indiana, United States

๐Ÿ‡บ๐Ÿ‡ธ

Source Health, Santa Monica, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Gershon Pain Specialists, Virginia Beach, Virginia, United States

and more 10 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath